Intentional coronary revascularization versus conservative therapy in patients after peripheral artery revascularization due to critical limb ischemia: the INCORPORATE trial.
Coronary angiography
Coronary artery disease
Critical limb ischemia
Fractional flow reserve
Journal
Clinical research in cardiology : official journal of the German Cardiac Society
ISSN: 1861-0692
Titre abrégé: Clin Res Cardiol
Pays: Germany
ID NLM: 101264123
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
08
04
2024
accepted:
25
06
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
aheadofprint
Résumé
INCORPORATE trial was designed to evaluate whether default coronary-angiography (CA) and ischemia-targeted revascularization is superior compared to a conservative approach for patients with treated critical limb ischemia (CLI). Registered at clinicaltrials.gov (NCT03712644) on October 19, 2018. Severe peripheral artery disease is associated with increased cardiovascular risk and poor outcomes. INCORPORATE was an open-label, prospective 1:1 randomized multicentric trial that recruited patients who had undergone successful CLI treatment. Patients were randomized to either a conservative or invasive approach regarding potential coronary artery disease (CAD). The conservative group received optimal medical therapy alone, while the invasive group had routine CA and fractional flow reserve-guided revascularization. The primary endpoint was myocardial infarction (MI) and 12-month mortality. Due to COVID-19 pandemic burdens, recruitment was halted prematurely. One hundred eighty-five patients were enrolled. Baseline cardiac symptoms were scarce with 92% being asymptomatic. Eighty-nine patients were randomized to the invasive approach of whom 73 underwent CA. Thirty-four percent had functional single-vessel disease, 26% had functional multi-vessel disease, and 90% achieved complete revascularization. Conservative and invasive groups had similar incidences of death and MI at 1 year (11% vs 10%; hazard ratio 1.21 [0.49-2.98]). Major adverse cardiac and cerebrovascular events (MACCE) trended for hazard in the Conservative group (20 vs 10%; hazard ratio 1.94 [0.90-4.19]). In the per-protocol analysis, the primary endpoint remained insignificantly different (11% vs 7%; hazard ratio 2.01 [0.72-5.57]), but the conservative approach had a higher MACCE risk (20% vs 7%; hazard ratio 2.88 [1.24-6.68]). This trial found no significant difference in the primary endpoint but observed a trend of higher MACCE in the conservative arm.
Sections du résumé
OBJECTIVES
OBJECTIVE
INCORPORATE trial was designed to evaluate whether default coronary-angiography (CA) and ischemia-targeted revascularization is superior compared to a conservative approach for patients with treated critical limb ischemia (CLI). Registered at clinicaltrials.gov (NCT03712644) on October 19, 2018.
BACKGROUND
BACKGROUND
Severe peripheral artery disease is associated with increased cardiovascular risk and poor outcomes.
METHODS
METHODS
INCORPORATE was an open-label, prospective 1:1 randomized multicentric trial that recruited patients who had undergone successful CLI treatment. Patients were randomized to either a conservative or invasive approach regarding potential coronary artery disease (CAD). The conservative group received optimal medical therapy alone, while the invasive group had routine CA and fractional flow reserve-guided revascularization. The primary endpoint was myocardial infarction (MI) and 12-month mortality.
RESULTS
RESULTS
Due to COVID-19 pandemic burdens, recruitment was halted prematurely. One hundred eighty-five patients were enrolled. Baseline cardiac symptoms were scarce with 92% being asymptomatic. Eighty-nine patients were randomized to the invasive approach of whom 73 underwent CA. Thirty-four percent had functional single-vessel disease, 26% had functional multi-vessel disease, and 90% achieved complete revascularization. Conservative and invasive groups had similar incidences of death and MI at 1 year (11% vs 10%; hazard ratio 1.21 [0.49-2.98]). Major adverse cardiac and cerebrovascular events (MACCE) trended for hazard in the Conservative group (20 vs 10%; hazard ratio 1.94 [0.90-4.19]). In the per-protocol analysis, the primary endpoint remained insignificantly different (11% vs 7%; hazard ratio 2.01 [0.72-5.57]), but the conservative approach had a higher MACCE risk (20% vs 7%; hazard ratio 2.88 [1.24-6.68]).
CONCLUSION
CONCLUSIONS
This trial found no significant difference in the primary endpoint but observed a trend of higher MACCE in the conservative arm.
Identifiants
pubmed: 38990250
doi: 10.1007/s00392-024-02487-2
pii: 10.1007/s00392-024-02487-2
doi:
Banques de données
ClinicalTrials.gov
['NCT03712644']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Teraa M, Conte MS, Moll FL, Verhaar MC (2016) Critical limb ischemia: current trends and future directions. J Am Heart Assoc 5. https://doi.org/10.1161/JAHA.115.002938
Adam DJ, Beard JD, Cleveland T et al (2005) Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366:1925–1934. https://doi.org/10.1016/S0140-6736(05)67704-5
doi: 10.1016/S0140-6736(05)67704-5
pubmed: 16325694
Bradbury AW, Adam DJ, Bell J et al (2010) Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg 51:5S-17S. https://doi.org/10.1016/j.jvs.2010.01.073
doi: 10.1016/j.jvs.2010.01.073
pubmed: 20435258
Farooq V, Serruys PW, Bourantas C et al (2012) Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) trial. Eur Heart J 33:3105–3113. https://doi.org/10.1093/eurheartj/ehs367
doi: 10.1093/eurheartj/ehs367
pubmed: 23103663
Farooq V, van Klaveren D, Steyerberg EW et al (2013) Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II. Lancet 381:639–650. https://doi.org/10.1016/S0140-6736(13)60108-7
doi: 10.1016/S0140-6736(13)60108-7
pubmed: 23439103
Toth G, Hamilos M, Pyxaras S et al (2014) Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J 35:2831–2838. https://doi.org/10.1093/eurheartj/ehu094
doi: 10.1093/eurheartj/ehu094
pubmed: 24644308
Lee MS, Rha S-W, Han SK et al (2015) Clinical outcomes of patients with critical limb ischemia who undergo routine coronary angiography and subsequent percutaneous coronary intervention. J Invasive Cardiol 27:213–217
pubmed: 25840405
Neumann F-J, Sousa-Uva M, Ahlsson A et al (2019) 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 40:87–165. https://doi.org/10.1093/eurheartj/ehy394
doi: 10.1093/eurheartj/ehy394
pubmed: 30165437
Mielniczuk LM, Toth GG, Xie JX et al (2017) Can functional testing for ischemia and viability guide revascularization? JACC Cardiovasc Imaging 10:354–364. https://doi.org/10.1016/j.jcmg.2016.12.011
doi: 10.1016/j.jcmg.2016.12.011
pubmed: 28279384
Toth G, Brodmann M, Barbato E et al (2019) Rational and design of the INtentional COronary revascularization versus conservative therapy in patients undergOing successful peripheRAl arTEry revascularization due to critical limb ischemia trial (INCORPORATE trial). Am Heart J 214:107–112. https://doi.org/10.1016/j.ahj.2019.05.005
doi: 10.1016/j.ahj.2019.05.005
pubmed: 31200280
Hardman R, Jazaeri O, Yi J et al (2014) Overview of classification systems in peripheral artery disease. Semin Intervent Radiol 31:378–388. https://doi.org/10.1055/s-0034-1393976
doi: 10.1055/s-0034-1393976
pubmed: 25435665
pmcid: 4232437
Perera D, Clayton T, O’Kane PD et al (2022) Percutaneous revascularization for ischemic left ventricular dysfunction. N Engl J Med. https://doi.org/10.1056/NEJMoa2206606
doi: 10.1056/NEJMoa2206606
pubmed: 36322842
Al-Lamee R, Thompson D, Dehbi H-M et al (2018) Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. The Lancet 391:31–40. https://doi.org/10.1016/S0140-6736(17)32714-9
doi: 10.1016/S0140-6736(17)32714-9
Maron DJ, Hochman JS, Reynolds HR et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395–1407. https://doi.org/10.1056/NEJMoa1915922
doi: 10.1056/NEJMoa1915922
pubmed: 32227755
pmcid: 7263833
Xaplanteris P, Fournier S, Pijls NHJ et al (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379:250–259. https://doi.org/10.1056/NEJMoa1803538
doi: 10.1056/NEJMoa1803538
pubmed: 29785878
Zimmermann FM, Omerovic E, Fournier S et al (2019) Fractional flow reserve-guided percutaneous coronary intervention vs. medical therapy for patients with stable coronary lesions: meta-analysis of individual patient data. Eur Heart J 40:180–186. https://doi.org/10.1093/eurheartj/ehy812
doi: 10.1093/eurheartj/ehy812
pubmed: 30596995
Dagenais GR, Lu J, Faxon DP et al (2013) Prognostic impact of the presence and absence of angina on mortality and cardiovascular outcomes in patients with type 2 diabetes and stable coronary artery disease. J Am Coll Cardiol 61:702–711. https://doi.org/10.1016/j.jacc.2012.11.036
doi: 10.1016/j.jacc.2012.11.036
pubmed: 23410541
pmcid: 3701296
Poredoš P, Jug B (2007) The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 58:309–315. https://doi.org/10.1177/0003319707302494
doi: 10.1177/0003319707302494
pubmed: 17626985
Hiatt WR, Goldstone J, Smith SC et al (2008) Atherosclerotic peripheral vascular disease symposium II. Circulation 118:2826–2829. https://doi.org/10.1161/CIRCULATIONAHA.108.191171
doi: 10.1161/CIRCULATIONAHA.108.191171
pubmed: 19106403
Murabito JM, Evans JC, Nieto K et al (2002) Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 143:961–965. https://doi.org/10.1067/mhj.2002.122871
doi: 10.1067/mhj.2002.122871
pubmed: 12075249
Criqui MH, Langer RD, Fronek A et al (1992) Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 326:381–386. https://doi.org/10.1056/NEJM199202063260605
doi: 10.1056/NEJM199202063260605
pubmed: 1729621
McKenna M, Wolfson S, Kuller L (1991) The ratio of ankle and arm arterial pressure as an independent predictor of mortality. Atherosclerosis 87:119–128. https://doi.org/10.1016/0021-9150(91)90014-T
doi: 10.1016/0021-9150(91)90014-T
pubmed: 1854359
Knuuti J, Ballo H, Juarez-Orozco LE et al (2018) The performance of non-invasive tests to rule-in and rule-out significant coronary artery stenosis in patients with stable angina: a meta-analysis focused on post-test disease probability. Eur Heart J 39:3322–3330. https://doi.org/10.1093/eurheartj/ehy267
doi: 10.1093/eurheartj/ehy267
pubmed: 29850808
Andreini D, Collet C, Leipsic J et al (2022) Pre-procedural planning of coronary revascularization by cardiac computed tomography: an expert consensus document of the Society of Cardiovascular Computed Tomography. EuroIntervention 18:e872–e887. https://doi.org/10.4244/EIJ-E-22-00036
doi: 10.4244/EIJ-E-22-00036
pubmed: 35994043
pmcid: 9743242
McFalls EO, Ward HB, Moritz TE et al (2004) Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351:2795–2804. https://doi.org/10.1056/NEJMoa041905
doi: 10.1056/NEJMoa041905
pubmed: 15625331